Home pagePress monitoringResearchers Isolate Protein Domain Linked to Tumor...

Researchers Isolate Protein Domain Linked to Tumor Progression

Datum: 23.2.2009 

When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix metalloproteinases (MMPs). Now, researchers at Rensselaer Polytechnic Institute have shown that creating drugs that inactivate a different part of the MMP enzyme could have the capacity to target the tumor without the damaging side effects. Their findings, which hold promise for improved cancer therapies, were published Feb. 5 in the online Early Edition of the Proceedings of the National Academy of Sciences (PNAS).

More news.rpi.edu

 

Czech Events

Seminář - Odstranění toxických polutantů z odpadních vod
BioInova, Praha, Česká republika, September 07, 2010

Národní informační den Regiony znalostí a výzkumný potenciál: Aktuální výzvy pro rok 2011
Aula rektorátu VUT, Antonínská 1, Brno, ČR, September 14, 2010

České fórum pro výzkum, vývoj a inovace 2010
Budova E, Mendelova univerzita v Brně, Brno, Česká republika, September 23, 2010

Provider

Jihočeská agentura pro podporu inovačního podnikání o.p.s.

Main Partner

MSB Technet

TOPlist